Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Eur Urol. 2013 Mar 13;64(3):372–378. doi: 10.1016/j.eururo.2013.03.005

Table 1.

Medical comorbidity of all 10 361 men treated for localized prostate cancer*

Medical
comorbidity		 Overall,
n = 10361		 RP,
n = 6477		 EBRT,
n = 2204		 BT,
n = 1680
None, no. (%) 6692 (65) 4459 (69) 1261 (57) 972 (58)
Mild, no. (%) 2615 (25) 1587 (25) 583 (26) 445 (26)
Moderate, no. (%) 922 (9) 387 (6) 300 (14) 235 (14)
Severe, no. (%) 132 (1) 44 (1) 60 (3) 28 (2)

RP = radical prostatectomy; EBRT = external-beam radiation therapy; BT = brachytherapy.

*

The Adult Comorbidity Evaluation Index-27 comorbidity index groups patients into none, mild, moderate, and severe. Charlson comorbidity index: 0 = none; 1 = mild; 2–3 = moderate; ≥4 = severe.